Grant: Planning and Dissemination Grant - Institute Community Support
University of British Columbia
$19,740.00
Ethical partnerships with transGender And Gender diverse communities for conducting pharmacoEpidemiologic research (EnGAGE)
FY 2021-22
Summary
HEALTH PROBLEM: Even though transgender and gender diverse people are more likely to have poorer mental and physical health, they face more barriers to getting the care they need. Likewise, the lack of health research about transgender individuals makes it challenging to address their care needs.
Many Canadians rely on prescription medications to help manage their health and treat diseases such as diabetes, heart disease, and arthritis. For medications to work, they need to be taken as prescribed which can be a challenge for many patients. We know that transgender people have unique health and medication needs, especially as they grow older. Yet, research on medication taking and how it affects health outcomes among transgender individuals is rare.
PLANNING SOLUTION: We aim to fill the transgender health data gap on medication taking through partnering with community stakeholders to develop research questions and priorities informed by the transgender community. First, we will review how sex and gender have been included in the available evidence on medication taking. Following, we will develop collaborations with Canadian patient, researcher, community, and institutional stakeholders through a series of planning activities. We will organize individual and group meetings with stakeholders to develop guidelines for collaboration, discuss research priorities, and design potential research studies. At the end of the year, we will hold a symposium to publicly showcase the impact of our planning activities, share insights on the collaborative process, and discuss plans for future research and advocacy collaborations. To widely share lessons learned by our team, we will create practical tools for researchers on developing ethical research partnerships with key stakeholder groups in the transgender community.
IMPORTANCE: Our planning activities will contribute to the design of transgender health research that is informed by the transgender community.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
460978
Name
Rebic Nevena
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Planning and Dissemination - IGH
Projecttitle
Ethical partnerships with transGender And Gender diverse communities for conducting pharmacoEpidemiologic research (EnGAGE)
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$19,740
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Administrative Health Data; Medication Adherence; Participatory Research Design; Patient-Oriented Research; Pharmacoepidemiology; Population-Based Studies; Sex And Gender Analysis; Transgender Health Research
Abstract
HEALTH PROBLEM: Even though transgender and gender diverse people are more likely to have poorer mental and physical health, they face more barriers to getting the care they need. Likewise, the lack of health research about transgender individuals makes it challenging to address their care needs.
Many Canadians rely on prescription medications to help manage their health and treat diseases such as diabetes, heart disease, and arthritis. For medications to work, they need to be taken as prescribed which can be a challenge for many patients. We know that transgender people have unique health and medication needs, especially as they grow older. Yet, research on medication taking and how it affects health outcomes among transgender individuals is rare.
PLANNING SOLUTION: We aim to fill the transgender health data gap on medication taking through partnering with community stakeholders to develop research questions and priorities informed by the transgender community. First, we will review how sex and gender have been included in the available evidence on medication taking. Following, we will develop collaborations with Canadian patient, researcher, community, and institutional stakeholders through a series of planning activities. We will organize individual and group meetings with stakeholders to develop guidelines for collaboration, discuss research priorities, and design potential research studies. At the end of the year, we will hold a symposium to publicly showcase the impact of our planning activities, share insights on the collaborative process, and discuss plans for future research and advocacy collaborations. To widely share lessons learned by our team, we will create practical tools for researchers on developing ethical research partnerships with key stakeholder groups in the transgender community.
IMPORTANCE: Our planning activities will contribute to the design of transgender health research that is informed by the transgender community.
Competitiondate
202202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rebic, Nevena
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Gender & Health~ $19,740~ $0~